Institut for Biomedicin

Thomas Vorup-Jensen

RECOMBINANT HUMAN MANNAN-BINDING LECTIN

Publikation: Patent

The present invention relates to methods of producing and/or isolating MEL compositions. In particular the inven­tion relates to methods of producing and/or isolating novel recombinant human MEL preparations with high similarity to natural human MEL. The MEL preparations may be used in compositions, medicaments and in methods for treatment of conditions such as those related to immunosuppressive conditions and/or to conditions of MEL deficiencies includ­ing latent conditions. Conditions of deficiencies of Mannan­Binding Lectin (MEL) are associated with increased sus­ceptibility to infections.
OriginalsprogEngelsk
PatentnummerUS 6,846,649 Bl
LandDanmark
Prioritetsdato14/05/1999
StatusUdgivet - 25 jan. 2005

    Forskningsområder

  • Biologisk terapi, rekonstitutionsterapi, innate immunity, complement

Se relationer på Aarhus Universitet Citationsformater

ID: 153443234